Literature DB >> 31600530

Epidemiology of lung cancer and lung cancer screening programs in China and the United States.

Dawei Yang1, Yang Liu2, Chunxue Bai3, Xiandong Wang4, Charles A Powell5.   

Abstract

Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ETS; Incidence; LDCT; Mortality; PM2.5

Year:  2019        PMID: 31600530     DOI: 10.1016/j.canlet.2019.10.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  59 in total

Review 1.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

2.  CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.

Authors:  Qian Lin; Hai Jun Wu; Qi Shi Song; Yu Kai Tang
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

Review 3.  Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications.

Authors:  Peilin Chen; Jianhang Hu; Xiaodong Han; Yabing Chen
Journal:  Mol Biol Rep       Date:  2022-01-13       Impact factor: 2.742

4.  MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.

Authors:  Junlei Han; Jianping Hu; Fang Sun; Hongzhi Bian; Bingxiang Tang; Xiang Fang
Journal:  Mol Cell Biochem       Date:  2020-10-30       Impact factor: 3.396

5.  Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma.

Authors:  Yu Cao; Hong Zhang; Jianming Tang; Rui Wang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

6.  Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation.

Authors:  Jia Wang; Nan Wu; Chao Lv; Shi Yan; Yue Yang
Journal:  Ann Transl Med       Date:  2020-02

7.  [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data.

Authors:  Jingjing Fu; Yan Xie; Tong Fu; Fan Qiu; Fei Yu; Wei Qu; Xiaochen Yao; Aiping Zhang; Zhenhua Yang; Guoqiang Shao; Qingle Meng; Xiumin Shi; Yue Huang; Wei Gu; Feng Wang
Journal:  EJNMMI Res       Date:  2021-06-13       Impact factor: 3.138

8.  Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.

Authors:  Yujiao Deng; Peng Zhao; Linghui Zhou; Dong Xiang; Jingjing Hu; Yu Liu; Jian Ruan; Xianghua Ye; Yi Zheng; Jia Yao; Zhen Zhai; Shuqian Wang; Si Yang; Ying Wu; Na Li; Peng Xu; Dai Zhang; Huafeng Kang; Jun Lyu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2020-07-20       Impact factor: 17.388

9.  The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990-2017.

Authors:  Xiaoxue Liu; Yong Yu; Minsheng Wang; Sumaira Mubarik; Fang Wang; Yafeng Wang; Runtang Meng; Chuanhua Yu
Journal:  Cancer Commun (Lond)       Date:  2020-10-08

10.  Interaction between common variants of MDM2 and PPP1R13L and CD3EAP and TP53 SNPs in relation to lung cancer risk among Chinese.

Authors:  Jiaoyang Yin; Wei Hou; Ulla Vogel; Yegang Ma; Chunhong Wang; Huiwen Wang; Zhenxiang Sun
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.